Circulating polyunsaturated fatty acids, pressure pain thresholds, and nociplastic pain conditions.
Chronic overlapping pain conditions
Epidemiology
Experimental pain sensitivity
Human
Polyunsaturated fatty acids
Quantitative sensory testing
Journal
Prostaglandins, leukotrienes, and essential fatty acids
ISSN: 1532-2823
Titre abrégé: Prostaglandins Leukot Essent Fatty Acids
Pays: Scotland
ID NLM: 8802730
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
received:
14
04
2022
revised:
22
07
2022
accepted:
22
07
2022
pubmed:
1
8
2022
medline:
14
9
2022
entrez:
31
7
2022
Statut:
ppublish
Résumé
Polyunsaturated fatty acids (PUFAs) play a role in pain regulation. This study sought to determine whether free PUFAs found in red blood cells also play a role in nociceptive processing. We examined associations between circulating PUFAs and nociceptive thresholds to noxious mechanical stimuli. We also determined whether nociceptive thresholds were associated with nociplastic pain conditions. This cross-sectional study used stored red bloods cells and data from 605 adult participants in the OPPERA-2 study of chronic overlapping pain conditions. In OPPERA-2 adults completed quantitative sensory testing in which pressure algometry measured deep muscular tissue sensitivity at six anatomical sites. Standardized protocols classified adults for presence or absence of five nociplastic pain conditions: temporomandibular disorder, headache, low back pain, irritable bowel syndrome and fibromyalgia. Liquid chromatography tandem mass spectroscopy quantified erythrocyte PUFAs. We conducted three sets of analyses. First, a multivariable linear regression model assessed the association between n-6/n-3 PUFA ratio and the number of overlapping nociplastic pain conditions. Second, a series of 36 multivariable linear regression models assessed covariate-adjusted associations between PUFAs and nociceptive thresholds at each of six anatomical sites. Third, a series of 30 multivariable linear regression models assessed covariate-adjusted associations between nociceptive thresholds at six anatomical sites and each of five pain conditions. In multiple linear regression, each unit increase in n-6/n-3 PUFA ratio was associated with more pain conditions (β = 0.30, 95% confidence limits: 0.07, 0.53, p = 0.012). Omega-6 linoleic acid and arachidonic acid were negatively associated with lower nociceptive thresholds at three and at five, respectively, anatomical sites. In contrast, omega-3 alpha-linolenic acid, eicosapentaenoic acid, docosahexaenoic acid and the n-6/n-3 PUFA ratio were not associated with nociceptive thresholds at any site. Pain cases had significantly lower nociceptive thresholds than non-case controls at all anatomical sites. A higher n-6/n-3 PUFA ratio was associated with more pain conditions. Omega-6 PUFAs may promote a generalized upregulation of nociceptive processing.
Identifiants
pubmed: 35908377
pii: S0952-3278(22)00088-6
doi: 10.1016/j.plefa.2022.102476
pmc: PMC10363286
mid: NIHMS1915534
pii:
doi:
Substances chimiques
Fatty Acids, Omega-3
0
Fatty Acids, Omega-6
0
Fatty Acids, Unsaturated
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
102476Subventions
Organisme : NIDCR NIH HHS
ID : R21 DE029746
Pays : United States
Informations de copyright
Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of Competing Interest None
Références
Nutrients. 2014 May 21;6(5):1993-2022
pubmed: 24853887
Curr Pharm Des. 2009;15(36):4135-48
pubmed: 20041815
Nutr J. 2020 Jul 11;19(1):70
pubmed: 32652993
J Pain. 2013 Dec;14(12 Suppl):T116-24
pubmed: 24275219
J Lipid Res. 2010 May;51(5):1186-92
pubmed: 19965606
J Pain. 2020 Jan - Feb;21(1-2):59-70
pubmed: 31154033
J Pain. 2013 Dec;14(12 Suppl):T2-19
pubmed: 24275220
Cephalalgia. 2012 Aug;32(11):822-33
pubmed: 22718556
PLoS One. 2015 Apr 13;10(4):e0123114
pubmed: 25875933
Front Pharmacol. 2019 Oct 15;10:1147
pubmed: 31680947
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
J Oral Facial Pain Headache. 2020 Suppl;34(Suppl):s43-s56
pubmed: 32975540
J Oral Facial Pain Headache. 2020 Suppl;34(Suppl):s85-s100
pubmed: 32975543
Biochem Pharmacol. 2022 Apr;198:114953
pubmed: 35149052
Sci Rep. 2017 Sep 7;7(1):10748
pubmed: 28883634
Biomed Res Int. 2015;2015:360825
pubmed: 26339608
Neurology. 2003 Aug 12;61(3):375-82
pubmed: 12913201
Gut. 1999 Sep;45 Suppl 2:II43-7
pubmed: 10457044
J Pain. 2011 Nov;12(11 Suppl):T61-74
pubmed: 22074753
Spine (Phila Pa 1976). 2008 Jan 1;33(1):95-103
pubmed: 18165754
BMJ. 2021 Jun 30;374:n1448
pubmed: 34526307
Front Med (Lausanne). 2022 Jun 16;9:923746
pubmed: 35783629
J Inflamm Res. 2017 Aug 29;10:119-133
pubmed: 28919798
Arthritis Rheum. 1990 Feb;33(2):160-72
pubmed: 2306288
Pain. 2005 Jun;115(3):410-418
pubmed: 15876494
Pain. 2020 Dec;161(12):2775-2785
pubmed: 32694380
Am J Clin Nutr. 1993 May;57(5 Suppl):801S-805S; discussion 805S-806
pubmed: 8475898
Am J Phys Med Rehabil. 2021 Jul 1;100(7):656-674
pubmed: 33002911
Int J Mol Sci. 2019 Jun 26;20(13):
pubmed: 31248061
Science. 2000 Jun 9;288(5472):1765-9
pubmed: 10846153
Br J Nutr. 2014 Feb;111(4):679-89
pubmed: 24063767
Ann Rheum Dis. 2016 Jan;75(1):23-9
pubmed: 26353789
J Oral Facial Pain Headache. 2020 Suppl;34(Suppl):s15-s28
pubmed: 32975538
Pain. 2007 May;129(1-2):210-23
pubmed: 17335973
Pain. 2016 Jul;157(7):1382-1386
pubmed: 26835783
Lancet. 2021 May 29;397(10289):2098-2110
pubmed: 34062144
Nat Med. 2010 May;16(5):592-7, 1p following 597
pubmed: 20383154
J Orofac Pain. 2011 Spring;25(2):161-9
pubmed: 21528123
Nat Metab. 2021 Jun;3(6):762-773
pubmed: 34140694
Ann Nutr Metab. 2018;72(2):117-125
pubmed: 29393106
Prostaglandins Leukot Essent Fatty Acids. 2018 Nov;138:71-80
pubmed: 27282298
Am J Clin Nutr. 1991 Oct;54(4):668-73
pubmed: 1832813
J Neurosci Res. 2017 Jun;95(6):1242-1256
pubmed: 27376591
J Transl Med. 2020 Oct 21;18(1):401
pubmed: 33087142
J Oral Facial Pain Headache. 2014 Winter;28(1):6-27
pubmed: 24482784
Gynecol Endocrinol. 1995 Dec;9(4):307-12
pubmed: 8629459